ULBI vs LIQT

For growth investors, Ultralife Corporation (ULBI) is the stronger pick with 16.

2% revenue growth year-over-year, versus 13. 0% for LiqTech International, Inc. (LIQT). Analysts rate Ultralife Corporation (ULBI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Ultralife Corporation (ULBI) delivered a total return of -23.

9%, compared to -96. 1% for LiqTech International, Inc. (LIQT). Over 10 years, the gap is even starker: ULBI returned +45. 3% versus LIQT's -91. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), LiqTech International, Inc.

(LIQT) is the lower-risk stock at 0. 54β versus Ultralife Corporation's 1. 44β — meaning ULBI is approximately 168% more volatile than LIQT relative to the S&P 500. On balance sheet safety, Ultralife Corporation (ULBI) carries a lower debt/equity ratio of 38% versus 117% for LiqTech International, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Ultralife Corporation (ULBI) is pulling ahead at 16.

2% versus 13. 0% for LiqTech International, Inc. (LIQT). On earnings-per-share growth, the picture is similar: LiqTech International, Inc. grew EPS 45. 7% year-over-year, compared to -192. 1% for Ultralife Corporation. Over a 3-year CAGR, ULBI leads at 13. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Ultralife Corporation (ULBI) is the more profitable company, earning -3.

1% net margin versus -51. 7% for LiqTech International, Inc. — meaning it keeps -3. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ULBI leads at 3. 3% versus -50. 3% for LIQT. At the gross margin level — before operating expenses — ULBI leads at 24. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, LiqTech International, Inc.

(LIQT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 54)). Both have compounded well over 10 years (LIQT: -91. 0%, ULBI: +45. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ULBI is a small-cap high-growth stock; LIQT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.